ENGINEERED BOTULINUM NEUROTOXIN

Disclosed herein are botulinum neurotoxin (BoNT) polypeptides with a modified receptor binding domain of Clostridial botulinum serotype B (B-Hc), comprising one or more substitution mutations corresponding to substitution mutations in serotype B, strain 1, V1118M; Y1183M; E1191M; E1191I; E1191Q; E11...

Full description

Saved in:
Bibliographic Details
Main Authors Dong Min, Peng Lisheng, Stenmark Pål Erik Gustav, Berntsson Ronnie Per Arne
Format Patent
LanguageEnglish
Published 10.08.2017
Subjects
Online AccessGet full text

Cover

Loading…